Triprolidine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for triprolidine hydrochloride and what is the scope of freedom to operate?
Triprolidine hydrochloride
is the generic ingredient in three branded drugs marketed by Glaxosmithkline, Usl Pharma, Alpharma Us Pharms, Halsey, Pharm Assoc, Vitarine, and Watson Labs, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for triprolidine hydrochloride.
Summary for triprolidine hydrochloride
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 7 |
NDAs: | 8 |
Drug Master File Entries: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Patent Applications: | 935 |
DailyMed Link: | triprolidine hydrochloride at DailyMed |
Medical Subject Heading (MeSH) Categories for triprolidine hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for triprolidine hydrochloride
US Patents and Regulatory Information for triprolidine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | ACTIDIL | triprolidine hydrochloride | SYRUP;ORAL | 011496-002 | Jul 1, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Vitarine | TRIPROLIDINE HYDROCHLORIDE | triprolidine hydrochloride | TABLET;ORAL | 085610-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | TRIPROLIDINE HYDROCHLORIDE | triprolidine hydrochloride | TABLET;ORAL | 085094-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharm Assoc | TRIPROLIDINE HYDROCHLORIDE | triprolidine hydrochloride | SYRUP;ORAL | 087514-001 | Feb 10, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |